Skip to main content

Type 1 Diabetes News

Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels. 

The International Diabetes Federation (IDF) is holding the Take a Step for Diabetes campaign to increase awareness for diabetes. This “step” can be a variety of actions...
On October 14, MannKind announced the resubmission of Afrezza, its ultra-rapid-acting inhaled insulin, to the FDA. The FDA had previously issued a complete response...
The remarkable work of Dr. Anne Peters at diaTribe and the Roybal Diabetes Management Center.
Five things people with diabetes need to know about the Affordable Care Act.
On April 24, Hyperion Therapeutics announced that it would acquire Andromeda Biotech. Andromeda is focused on the development of a first-in-class immune therapy for new...
On July 10, the JDRF and 161 delegates for the Children’s Congress traveled to Capitol Hill inWashington, D.C. to call for support of type 1 diabetes research funding...
Why Targeting a Cure has been such a deeply personal endeavor for Kelly.
The technology giant, Google recently announced that it is working to develop a contact lens that could non-invasively monitor glucose levels from tears. The smart...
On April 17, Abbott announced a recall of the FreeStyle InsuLinx blood glucose meters due to software issues for readings of 1,024 mg/dl and above. The problem is...
(S)he said what!?
On September 9, the Diabetes Technology Society (DTS) held a meeting on how best to actively monitor blood glucose meter quality after FDA approval. The meeting included...
(S)he said what!?
On January 21, Glooko and Joslin announced a partnership to develop a new web/mobile-based diabetes management platform. The system will combine a “Virtual Joslin”...
Cellnovo recently launched its mobile-enabled insulin pump system in the UK, after receiving very positive feedback from a usability study that began in the UK in...
On May 31 and June 17, MannKind announced that it had completed its new phase 3 clinical studies of Afrezza for people with type 1 and 2 diabetes. As a reminder, Afrezza...
The New York Times publishes a critical front page piece on type 1 diabetes costs and devices - what we wish they would have written.
iHealth Labs recently announced the launch of its wireless Smart-Gluco Monitoring system in the US. Similar in principle to LifeScan's OneTouch VerioSync ( cleared by...
What apps are best for diabetes? What we learned at this year’s AADE 2013.
The three top trends we saw in diabetes in 2013.

Pages